Fistulectomy and Primary Sphincter rEconstruction vs. endorectaL Advancement Flap in the Treatment of High Anal Fistulas (SELF)

February 26, 2020 updated by: Russian Society of Colorectal Surgeons

Fistulectomy With Primary Sphincter Reconstruction vs. Muco-muscular Endorectal Advancement Flap in the Treatment of High Transsphincteric Anal Fistulas

The optimal method of surgical treatment of complex anorectal fistulas has not been found yet.

The aim of this study is to compare two techniques in treatment of high anorectal fistulas. This study purpose to demonstrate that the fistulectomy with dissection from 1/3 to 2/3 of the height of the sphincter complex with primary suturing is technically simpler, equally effective and safe in comparison with muco-muscular endorectal advancement flap.

Study Overview

Detailed Description

Anorectal fistula is a common proctological disease with prevalence between 8.6 and 10 per 100,000 population. Surgical treatment of complex anorectal fistulas has two main objectives: preventing the recurrence of the disease and preserving the anal continence. The optimal principle of management of patients with anorectal fistulas includes a comprehensive preoperative examination with the definition of the architectonics of the fistulous tract, the identification of the internal fistulous opening, the elimination of additional tracts and cavities.

Many methods are used for high anorectal fistula's treatment, but the optimal strategy has not been found yet.

Nowadays, the conventional sphincter-preserving operation for the treatment of complex anorectal fistulas is advancement rectal flap. In addition, plastic with a full-thickness flap in comparison with a mucosal flap was associated with less reccurence rate (10% and 40% respectively), and was accompanied by manifestation of incontinence symptoms, increased with the thickness of the flap.

About 20 years ago, in an attempt to reduce high level of incontinence, the primary reconstruction of sphincters after fistulotomy was proposed; however, this technique is still debated.

According to reports, dissection of more than 1/3 of the sphincter increases the incidence of postoperative incontinence. However, fistulectomy with primary suturing of the sphincter defect allows to improve the function of anal continence and is recommended for patients with initial incontinence after previous surgical interventions.

The studie's aim is comparison between two techniques in treatment of high anorectal fistulas. This study purpose to demonstrate that the fistulectomy with dissection from 1/3 to 2/3 of the height of the sphincter complex with primary suturing is technically simpler, equally effective and safe in comparison with muco-muscular endorectal advancement flap.

Study Type

Interventional

Enrollment (Anticipated)

142

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Moscow, Russian Federation, 119435
        • Recruiting
        • Clinic of Colorectal and Minimally Invasive Surgery
        • Sub-Investigator:
          • Daniil Markaryan, PhD
        • Sub-Investigator:
          • Yuliia Churina, MD
        • Sub-Investigator:
          • Yuliia Medkova, MD
        • Sub-Investigator:
          • Inna Tulina, PhD
        • Contact:
        • Principal Investigator:
          • Petr Tsarkov, Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient's consent to participate in the study
  2. Patient's consent for surgery
  3. High transsphincteric anorectal fistula, involving from 1/3 to 2/3 of the height of the sphincter according to the both MRI and intraoperative revision
  4. Cryptoglandular fistulas
  5. The absence of incontinence before the operation in accordance with the classification CCFF-IS
  6. Preoperative MR-diagnostics before the operation

Exclusion Criteria:

  1. Refuse of the patient to participate in the study.
  2. Low transsphincteric (involving less than 1/3 of the height of the sphincter according to MRI), intersphincteric, extrasphincteric fistula of the rectum.
  3. Recurrent fistula.
  4. Rectovaginal or rectourethral fistula.
  5. Anal incontinence (Appendix 2).
  6. Pregnancy.
  7. Inflammatory bowel disease (confirmed endoscopically and morphologically).
  8. Patients with immunodepression (i.e. HIV)
  9. The presence of an acute purulent process in the perianal area.
  10. Anterior anorectal fistula in female.
  11. The inability to perform MRI of the pelvic organs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Muco-muscular endorectal advancement flap
After fistulectomy a muco-muscular endorectal advancement flap is mobilised and fixed to anoderma
After fistulectomy muco-muscular flap of the rectal wall will be mobilized. The muscular defect is sutured with separate interrupted sutures (Vicryl / Polysorb 2/0, 0/0, 3/0). The muco-muscular flap is fixed to the anoderm without tension by interrupted sutures (Vicryl / Polysorb 4/0). The wound of the perianal area is not sutured.
Experimental: Primary sphincter reconstruction
After fistulectomy the defect in anal sphincters is closed
Fistulectomy will be performed. The affected gland is visualized and removed. If there are secondary extensions, they are excised also. Sphincter defect with stitches (suture material Vicryl / Polysorb 2/0, 0/0, 3/0) with restoration of the anal canal profile (suturing of the anodermal-skin border). The skin is not suturing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incontinence rate
Time Frame: 1 day - 1 year
The frequency of incontinence after the operation in accordance with the classification CCFF-IS (Cleveland Clinic Florida Faecal Incontinence Score). 0 points - total continence, 24 points - complete incontinence.
1 day - 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intencity
Time Frame: 1 day, 7 day, 14 day, 30 day
The severity of pain in the postoperative period according to VAS score (visual analogue pain scale). Interpretation of values: no pain (0 points), mild pain (1-4 points), moderate pain (5-9 points), severe pain (10 points).
1 day, 7 day, 14 day, 30 day
Recurrence rate
Time Frame: 1 day - 1 year
The frequency of recurrence of the disease in the comparison groups during the observation period.
1 day - 1 year
Wound healing
Time Frame: 30 day - 90 day
The duration of wound healing in the perianal area and anus
30 day - 90 day
Overall quality of life
Time Frame: assessed after surgery: 14 day, 1 month, 3 month, 6 month, 1 year
Assessed with patient-reported questionnaire SF-36 (Short-form 36 Questionnaire). A total score in each of 8 sections will be calculated and transformed into a 0-100 scale with a score of zero equivalent to maximum disability and a score of 100 equivalent to no disabilityusing the SF-36 questionnaire.
assessed after surgery: 14 day, 1 month, 3 month, 6 month, 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2017

Primary Completion (Anticipated)

February 20, 2020

Study Completion (Anticipated)

March 7, 2020

Study Registration Dates

First Submitted

October 6, 2019

First Submitted That Met QC Criteria

October 6, 2019

First Posted (Actual)

October 8, 2019

Study Record Updates

Last Update Posted (Actual)

February 28, 2020

Last Update Submitted That Met QC Criteria

February 26, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anal Fistula

Clinical Trials on Muco-muscular endorectal advancement flap after fistulectomy

3
Subscribe